Stimulation-induced gene expression in Ramos B-cells

Genes and Immunity

Volumn 4, Issue 5, 2003, Pages 343-350

  Ollila, J ^a   Vihinen, Mauno ^b,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

B lymphocytes; cDNA microarray; Cellular differentiation; Gene regulation; Human

Indexed keywords

COMPLEMENTARY DNA; IMMUNOGLOBULIN M; PROTEIN; ANTI-IGM; ANTIIDIOTYPIC ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; RNA;

APOPTOSIS; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; BIOINFORMATICS; CELL CYCLE; CONTROLLED STUDY; DNA MICROARRAY; EARLY RESPONSE GENE; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE TARGETING; GENETIC CODE; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; MEDICAL RESEARCH; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; UNINDEXED SEQUENCE; ANTIBODY PRODUCTION; B LYMPHOCYTE; GENE EXPRESSION; GENETICS; IMMUNIZATION; IMMUNOLOGY;

ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODY FORMATION; APOPTOSIS; B-LYMPHOCYTES; CELL CYCLE; GENE EXPRESSION; HUMANS; IMMUNIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA;

EID: 1542707363     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363974     Document Type: Article

References (51)

1. Benschop RJ, Cambier JC. B-cell development: signal transduction by antigen receptors and their surrogates. Curr Opin Immunol 1999; 11: 143-151.
2. Cambier JC. New nomenclature for the Reth motif (or ARH1/TAM/ARAM/YXXL). Immunol Today 1995; 16: 110.
3. Cambier JC, Ransom JT. Molecular mechanisms of transmembrane signaling in B lymphocytes. Annu Rev Immunol 1987; 5: 175-199.
4. Law CL, Craxton A, Otipoby KL, Sidorenko SP, Klaus SJ, Clark EC. Regulation of signalling through B-lymphocyte antigen receptors by cell-cell interaction molecules. Immunol Rev 1996; 153: 123-154.
5. Boise LH, Thompson CB. Hierarchical control of lymphocyte survival. Science 1996; 274: 67-68.
6. Cambier JC, Monroe JG. B-cell activation. V. Differentiation signaling of B-cell membrane depolarization, increased I-A expression, G0 to G1 transition, and thymidine uptake by anti-IgM and anti-IgD antibodies. J Immunol 1984; 133: 576-581.
7. Sieckmann DG. The use of anti-immunoglobulins to induce a signal for cell division in B lymphocytes via their membrane IgM and IgD. Immunol Rev 1980; 52: 181-210.
8. Alizadeh AA, Eisen MB, Davis RE et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503-511.
9. Aalto Y, El-Rifai W, Vilpo L et al. Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion. Leukemia 2001; 15: 1721-1728.
10. Alizadeh A, Eisen M, Botstein D, Brown PO, Staudt LM. Probing lymphocyte biology by genomic-scale gene expression analysis. J Clin Immunol 1998; 18: 373-379.
11. Ollila J, Vihinen M. Stimulation of B and T cells activates expression of transcription and differentiation factors. Biochem Biophys Res Commun 1998; 249: 475-480.
12. Ollila J, Vihinen M. Microarray analysis of B-cell stimulation. Vitam Horm 2002; 64: 77-99.
13. Fitzsimmons D, Hagman J. Regulation of gene expression at early stages of B-cell and T-cell differentiation. Curr Opin Immunol 1996; 8: 166-174.
14. Kelly K, Siebenlist U. Immediate-early genes induced by antigen receptor stimulation. Curr Opin Immunol 1995; 7: 327-332.
15. Fleckner J, Martensen PM, Tolstrup AB, Kjeldgaard NO, Justesen J. Differential regulation of the human, interferon inducible tryptophanyl-tRNA synthetase by various cytokines in cell lines. Cytokine 1995; 7: 70-77.
16. Krzysiek R, Lefevre EA, Zou W et al. Antigen receptor engagement selectively induces macrophage inflammatory protein-1 alpha (MIP-1 alpha) and MIP-1 beta chemokine production in human B-cells. J Immunol 1999; 162: 4455-4463.
17. Clevers HC, Grosschedl R. Transcriptional control of lymphoid development: lessons from gene targeting. Immunol Today 1996; 17: 336-343.
18. Glimcher LH, Singh H. Transcription factors in lymphocyte development - T and B-cells get together. Cell 1999; 96: 13-23.
19. Lawrence HJ, Helgason CD, Sauvageau G et al. Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood 1997; 89: 1922-1930.
20. Ohnishi K, Tobita T, Sinjo K, Takeshita A, Ohno R. Modulation of homeobox B6 and B9 genes expression in human leukemia cell lines during myelomonocytic differentiation. Leuk Lymphoma 1998; 31: 599-608.
21. Meazza R, Faiella A, Corsetti MT et al. Expression of HOXC4 homeoprotein in the nucleus of activated human lymphocytes. Blood 1995; 85: 2084-2090.
22. Bhargava AK, Li Z, Weissman SM. Differential expression of four members of the POU family of proteins in activated and phorbol 12-myristate 13-acetate-treated Jurkat T cells. Proc Natl Acad Sci USA 1993; 90: 10260-10264.
23. Budhram-Mahadeo V, Morris PJ, Smith MD, Midgley CA, Boxer LM, Latchman DS. p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor. J Biol Chem 1999; 274: 15237-15244.
24. Lewis MT, Ross S, Strickland PA, Snyder CJ, Daniel CW. Regulated expression patterns of IRX-2, an Iroquois-class homeobox gene, in the human breast. Cell Tissue Res 1999; 296: 549-554.
25. Lin CK, Zou HY, Kaptein JS et al. Anti-IgM-induced growth inhibition and apoptosis are independent of ornithine decarboxylase in Ramos cells. Exp Cell Res 1997; 237: 231-241.
26. de Falco G, Giordano A. CDK9 (PITALRE): a multifunctional cdc2-related kinase. J Cell Physiol 1998; 177: 501-506.
27. Zhang H, Kobayashi R, Galaktionov K, Beach D. p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell 1995; 82: 915-925.
28. Kimura SH, Tsuruga H, Yabuta N, Endo Y, Nojima H. Structure, expression, and chromosomal localization of human GAK. Genomics 1997; 44: 179-187.
29. Weinstein J. Cell cycle-regulated expression, phosphorylation, and degradation of p55Cdc. A mammalian homolog of CDC20/Fizzy/slp1. J Biol Chem 1997; 272: 28501-28511.
30. Kao CT, Lin M, O'Shea-Greenfield A, Weinstein J, Sakamoto KM. Over-expression of p55Cdc inhibits granulocyte differentiation and accelerates apoptosis in myeloid cells. Oncogene 1996; 13: 1221-1229.
31. Lin M, Mendoza M, Kane L, Weinstein J, Sakamoto KM. Analysis of cell death in myeloid cells inducibly expressing the cell cycle protein p55Cdc. Exp Hematol 1998; 26: 1000-1006.
32. Sadhu K, Reed SI, Richardson H, Russell P. Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2. Proc Natl Acad Sci USA 1990; 87: 5139-5143.
33. Morris MC, Heitz A, Mery J, Heitz F, Divita G. An essential phosphorylation-site domain of human cdc25C interacts with both 14-3-3 and cyclins. J Biol Chem 2000; 275: 28849-28857.
34. Chen F, Studzinski GP. Cyclin-dependent kinase 5 activity enhances monocytic phenotype and cell cycle traverse in 1,25-dihydroxyvitamin D3-treated HL60 cells. Exp Cell Res 1999; 249: 422-428.
35. Morse L, Chen D, Franklin D, Xiong Y, Chen-Kiang S. Induction of cell cycle arrest and B-cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6. Immunity 1997; 6: 47-56.
36. Cohen JJ. Programmed cell death in the immune system. Adv Immunol 1991; 50: 55-85.
37. Toledano BJ, Bastien Y, Noya F, Baruchel S, Mazer B. Platelet-activating factor abrogates apoptosis induced by cross-linking of the surface IgM receptor in a human B lymphoblastoid cell line. J Immunol 1997; 158: 3705-3715.
38. Mongini PK, Liu Q, Vilensky MA, Highet PF, Inman JK. Evidence for an upper affinity threshold for anti-IgM-induced apoptosis in a human B-cell lymphoma. Blood 1998; 92: 3756-3771.
39. Jones TL, Lafrenz D. Quantitative determination of the induction of apoptosis in a murine B-cell line using flow cytometric bivariate cell cycle analysis. Cell Immunol 1992; 142: 348-360.
40. Valentine MA, Licciardi KA. Rescue from anti-IgM-induced programmed cell death by the B-cell surface proteins CD20 and CD40. Eur J Immunol 1992; 22: 3141-3148.
41. Toledano BJ, Bastien Y, Noya F, Mazer B. Characterization of B lymphocytes rescued from apoptosis by platelet- activating factor. Cell Immunol 1999; 191: 60-68.
42. Nakashima T, Sekiguchi T, Kuraoka A et al. Molecular cloning of a human cDNA encoding a novel protein, DAD1, whose defect causes apoptotic cell death in hamster BHK21 cells. Mol Cell Biol 1993; 13: 6367-6374.
43. Ruiz-Vela A, Gonzalez de Buitrago G, Martinez AC. Implication of calpain in caspase activation during B-cell clonal deletion. Embo J 1999; 18: 4988-4998.
44. Scaffidi C, Kirchhoff S, Krammer PH, Peter ME. Apoptosis signaling in lymphocytes. Curr Opin Immunol 1999; 11: 277-285.
45. Guedez L, Stetler-Stevenson WG, Wolff L et al. In vitro suppression of programmed cell death of B-cells by tissue inhibitor of metalloproteinases-1. J Clin Invest 1998; 102: 2002-2010.
46. Su L, David M. Inhibition of B-cell receptor-mediated apoptosis by IFN. J Immunol 1999; 162: 6317-6321.
47. Ribeiro P, Renard N, Warzocha K et al. CD40 regulation of death domains containing receptors and their ligands on lymphoma B-cells. Br J Haematol 1998; 103: 684-689.
48. Schneider P, Thome M, Burns K et al. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity 1997; 7: 831-836.
49. Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 1995; 81: 495-504.
50. Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, Ashkenazi A. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 2000; 12: 611-620.
51. Tamayo P, Slonim D, Mesirov J et al. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc Natl Acad Sci USA 1999; 96: 2907-2912.